Dr. Hammoudeh is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
268 Martin Luther King Jr Blvd
Newark, NJ 07102- Is this information wrong?
Education & Training
University of Jordan Faculty of MedicineClass of 1986
New York Medical College at St Michael's Medical CenterResidency, Internal Medicine
Seton Hall University-Hackensack Meridian School of MedicineFellowship, Interventional Cardiology
Certifications & Licensure
NJ State Medical License 1991 - 2015
Awards, Honors, & Recognition
- Fellow (FACC) American College of Cardiology
Clinical Trials
- Statin Eligibility Prior to Myocardial InfarCtion Start of enrollment: 2019 Apr 22
- Surviving a Decade or More After Coronary Revascularization in a Middle Eastern Population Start of enrollment: 2018 Jun 01
- The Jordan Atrial Fibrillation Study: Baseline Risk Scores and One Year Outcome Start of enrollment: 2019 May 25
Roles: Study Chair, Contact, Sponsor-Investigator
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsReality of obesity paradox: Results of percutaneous coronary intervention in Middle Eastern patients.Mohamad I Jarrah, Ayman J. Hammoudeh, Yousef Khader, Ramzi Tabbalat, Eyas Al-Mousa, Osama Okkeh, Imad A. Alhaddad, Loai Issa Tawalbeh, Issa M. Hweidi> ;The Journal of International Medical Research. 2018 Feb 22
- 9 citationsCardiovascular risk factors in Middle Eastern patients undergoing percutaneous coronary intervention: Results from the first Jordanian percutaneous coronary interventi...Ayman J. Hammoudeh, Imad A. Alhaddad, Yousef Khader, Ramzi Tabbalat, Eyas Al-Mousa, Akram Saleh, Mohamad I Jarrah, Assem Nammas, Mahmoud Izraiq> ;Journal of the Saudi Heart Association. 2017 Jul 1
- 3 citationsMajor bleeding events in Jordanian patients undergoing percutaneous coronary intervention (PCI): Incidence, associated factors, impact on prognosis, and predictability...Mohamad I Jarrah, Ayman J. Hammoudeh, Osama Okkeh, Yousef Khader, Sahem Gharaibeh, Laith Nasser, Amro Rasheed, Ayed Al-hindi, Mohammad Mohealdeen, Haneen Kharabsheh, H...> ;Anatolian Journal of Cardiology. 2017 Jun 1
- Join now to see all
Press Mentions
Cardiovascular Risk Categories and Attaining LDL-C Targets in Middle Eastern Adults Aged 30-55 Years of Age (CREATE)February 27th, 2023- Cardiovascular Patients with No Standard Modifiable Risk Factors (SMuRF-Less-ME1)January 13th, 2024
- Cardiovascular Risk Categories and Attaining LDL-C Targets in Middle Eastern Adults Aged 30-55 Years of Age (CREATE)October 5th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
